Nuvectis Pharma Statistics
NASDAQ: NVCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.39-0.45 (-2.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nuvectis Pharma by the numbers
Nuvectis Pharma has a market capitalization of $666.8 million based on 34.39M shares outstanding. With trailing EPS of $-2.00, Nuvectis Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.0% below its 50-day average and 25.4% above its 200-day average.
Average daily trading volume is 206.37K shares, or about $4.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVCT valuation vs. peer median
| Metric | NVCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $666.80M | $641.45M | +4% |
| Avg. volume | 206.37K | 1.25M | -84% |
Peer median across 8 companies: APMD, LXRX, SGMT, KURA, JANX, ABUS, OLMA, OBX.
Valuation
- Market cap
- $666.80M
- EPS (TTM)
- $-2.00
- Shares outstanding
- 34.39M
Price and trading
- Previous close
- 19.84
- Open
- 19.60
- Day range
- 19.02 – 20.18
- 52-week range
- 5.77 – 29.28
- 52-week change
- +218.91%
- Beta
- —
- Volume
- 301.60K
- Average volume
- 206.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 666.80M
- Forward Pe
- -20.20
- Eps
- -2.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.28
- Week52 Low
- 5.77
- Avg Volume
- 206.37K
- Shares Outstanding
- 34.39M
- Ma50
- 20.21
- Ma200
- 15.46
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -33.77%
- Pct From52w Low
- 236.05%